Monday, November 10, 2025
HomeIndustriesBiotechnology

Biotechnology

Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882 as Potential New Therapeutic Approach for Diffuse Large B-Cell Lymphoma

Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, announced positive preclinical data for its lead small...

Read Magazine’s Weekly Roundup: Discover the Most Recent News From Capella Space, Veoneer, Connexions, Immunitas Therapeutics, MSA Safety, Caresyntax, And Many More !

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

Myeloid Announces Appointment of Matthew Maurer, M.D. as Chief Medical Officer

Myeloid Therapeutics, Inc., a clinical stage oncology company, has appointed Matthew Maurer, M.D. as Chief Medical Officer. Dr. Maurer is an experienced physician-scientist with...

Immunitas Therapeutics Announces Appointment of James Wooldridge as Chief Medical Officer and Upcoming Presentation at ASH 2023 Annual Meeting

Immunitas Therapeutics, a clinical stage precision immunotherapy company committed to discovering and developing novel, differentiated therapeutics for patients with cancer, announced the appointment of...

Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, will present new data and study results across its Precision Oncology and...
0FansLike
0FollowersFollow
spot_img

Hot Topics